These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7576 related articles for article (PubMed ID: 25543409)

  • 21. A case of superficial spreading melanoma in situ 2.5 mm in diameter.
    Ban M; Yoneda K; Yanagihara M; Mori S; Seko T
    J Dermatol; 1993 Jul; 20(7):432-5. PubMed ID: 8408926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant melanoma within an intradermal nevus.
    Tajima Y; Nakajima T; Sugano I; Nagao K; Kondo Y
    Am J Dermatopathol; 1994 Jun; 16(3):301-6. PubMed ID: 7943639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell-defined melanoma antigens: toward a tumour-specific immunotherapy of the disease.
    Parmiani G
    Melanoma Res; 1993 Dec; 3(6):391-3. PubMed ID: 7909243
    [No Abstract]   [Full Text] [Related]  

  • 24. A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring.
    Dummer R; Gore ME; Hancock BW; Guillou PJ; Grobben HC; Becker JC; Oskam R; Dieleman JP; Burg G
    Cancer; 1995 Feb; 75(4):1038-44. PubMed ID: 7842406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of malignant melanoma by Tc-99m HMPAO.
    Ryu YH; Chung TS; Lee JD; Suh JH; Lee JT; Park CY
    Clin Nucl Med; 1995 Jun; 20(6):528-30. PubMed ID: 7648739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiosensitizer AK-2123 as modulating agent in the chemotherapy of experimental metastases.
    Konovalova NP; Diatchkovskaya RF; Volkova LM; Kagiya TV
    Neoplasma; 1995; 42(3):119-22. PubMed ID: 7637820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant hypomelanotic melanoma of mules. A histologic, immunohistochemical and ultrastructural study of a case with unknown primary site and widespread metastases.
    Giuffré G; Muscarella A; Muscarà M; Todaro P; Tuccari G
    Pathologica; 1995 Feb; 87(1):100-4. PubMed ID: 7567160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor activity and toxicity of cisplatin analogs.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Treat Rep; 1982 Jan; 66(1):135-46. PubMed ID: 7198010
    [No Abstract]   [Full Text] [Related]  

  • 29. [Organization of microtubules and regulation of cell growth].
    Sato C
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):638-43. PubMed ID: 6370143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatic cell hybrids producing inhibitors of melanotic melanoma tyrosine hydroxylase.
    Hakim AA
    Experientia; 1982 Feb; 38(2):267-70. PubMed ID: 6120853
    [No Abstract]   [Full Text] [Related]  

  • 31. The p97 antigen is mapped to the q24-qter region of chromosome 3; the same region as the transferrin receptor.
    Seligman PA; Butler CD; Massey EJ; Kaur JA; Brown JP; Plowman GD; Miller Y; Jones C
    Am J Hum Genet; 1986 Apr; 38(4):540-8. PubMed ID: 3010712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma.
    Koprowski H; Herlyn M; Balaban G; Parmiter A; Ross A; Nowell P
    Somat Cell Mol Genet; 1985 May; 11(3):297-302. PubMed ID: 2988138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear retinoic-acid-binding proteins and receptors in retinoic-acid-responsive cell lines.
    Daly AK; Rees JL; Redfern CP
    Exp Cell Biol; 1989; 57(6):339-45. PubMed ID: 2562438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of soluble E-receptor in the serum of patients with various diseases and its accompanying in vitro immunosuppression in neoplasia.
    Oh SK; Lapenson D; Morgan AC
    Scand J Immunol; 1985 Jul; 22(1):51-60. PubMed ID: 3875146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aneurysmal dermatofibroma mimicking both clinical and dermoscopic malignant melanoma and Kaposi's sarcoma.
    Morariu SH; Suciu M; Vartolomei MD; Badea MA; Cotoi OS
    Rom J Morphol Embryol; 2014; 55(3 Suppl):1221-4. PubMed ID: 25607410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-thujaplicin zinc chelate induces apoptosis in mouse high metastatic melanoma B16BL6 cells.
    Miyamoto D; Endo N; Oku N; Arima Y; Suzuki T; Suzuki Y
    Biol Pharm Bull; 1998 Dec; 21(12):1258-62. PubMed ID: 9881634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists.
    Tubbs RR; Nagle R; Leslie K; Pettigrew NM; Said JW; Corwin DJ; Rickert RR; Roche PC
    Arch Pathol Lab Med; 1998 Dec; 122(12):1051-2. PubMed ID: 9870851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxic and anticancer activities of some 1-aryl-2-dimethylaminomethyl-2-propen-1-one hydrochlorides.
    Dimmock JR; Vashishtha SC; Patil SA; Udupa N; Dinesh SB; Devi PU; Kamath R
    Pharmazie; 1998 Oct; 53(10):702-6. PubMed ID: 9812337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study.
    Wolf P; Quehenberger F; Müllegger R; Stranz B; Kerl H
    Melanoma Res; 1998 Aug; 8(4):370-8. PubMed ID: 9764814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary experience with high-dose cisplatin, reduced glutathione and natural interferon-alpha in dacarbazine-resistant malignant melanoma.
    Bajetta E; Rimassa L; Carnaghi C; Del Vecchio M; Celio L; Cassata A
    Tumori; 1998; 84(1):48-51. PubMed ID: 9619714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 379.